Cargando…

Glioma Stem-Like Cells Can Be Targeted in Boron Neutron Capture Therapy with Boronophenylalanine

SIMPLE SUMMARY: Glioblastoma is the most lethal tumor among all cancers with a median overall survival of 14 months and to develop new effective therapies is an urgent issue. Boron Neutron Capture Therapy (BNCT) is a unique radiation therapy that uses boron compounds and thermal neutrons. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kondo, Natsuko, Hikida, Masaki, Nakada, Mitsutoshi, Sakurai, Yoshinori, Hirata, Eishu, Takeno, Satoshi, Suzuki, Minoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603373/ https://www.ncbi.nlm.nih.gov/pubmed/33086625 http://dx.doi.org/10.3390/cancers12103040

Ejemplares similares

5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy
por: Fukumura, Masao, et al.
Publicado: (2023)

Central nervous system tolerance to boron neutron capture therapy with p-boronophenylalanine.
por: Morris, G. M., et al.
Publicado: (1997)

The Therapeutic Effects of Dodecaborate Containing Boronophenylalanine for Boron Neutron Capture Therapy in a Rat Brain Tumor Model
por: Fukuo, Yusuke, et al.
Publicado: (2020)

Analysis of boron neutron capture reaction sensitivity using Monte Carlo simulation and proposal of a new dosimetry index in boron neutron capture therapy
por: Takeno, Satoshi, et al.
Publicado: (2022)

The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2014)

ACT-3 Reactor-based boron neutron capture therapy with add-on bevacizumab for recurrent malignant glioma: The final report
por: Furuse, Motomasa, et al.
Publicado: (2021)

NI-04 Evaluation of post boron neutron capture therapy for recurrent meningioma using fluoride-labeled boronophenylalanine PET
por: Takai, Satoshi, et al.
Publicado: (2020)

Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB(0,+), LAT1 and LAT2
por: Wongthai, Printip, et al.
Publicado: (2015)

A case of radiation-induced osteosarcoma treated effectively by boron neutron capture therapy
por: Futamura, Gen, et al.
Publicado: (2014)

Boron Neutron Capture Therapy for Malignant Brain Tumors
por: MIYATAKE, Shin-Ichi, et al.
Publicado: (2016)

Boron Neutron Capture Therapy Combined with Early Successive Bevacizumab Treatments for Recurrent Malignant Gliomas – A Pilot Study
por: SHIBA, Hiroyuki, et al.
Publicado: (2018)

Poly(vinyl alcohol) boosting therapeutic potential of p-boronophenylalanine in neutron capture therapy by modulating metabolism
por: Nomoto, Takahiro, et al.
Publicado: (2020)

Effect of bevacizumab combined with boron neutron capture therapy on local tumor response and lung metastasis
por: MASUNAGA, SHIN-ICHIRO, et al.
Publicado: (2014)

Applicability of Combination with Tirapazamine in Boron Neutron Capture Therapy
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1998)

Evaluation of the Key Advantages between Two Modalities of Boronophenylalanine Administration for Clinical Boron Neutron Capture Therapy Using an Animal Model
por: Lin, Yu-Chuan, et al.
Publicado: (2022)

Evaluating the Usefulness of a Novel (10)B-Carrier Conjugated With Cyclic RGD Peptide in Boron Neutron Capture Therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2012)

The Effects of Boron Neutron Capture Therapy on Liver Tumors and Normal Hepatocytes in Mice
por: Suzuki, Minoru, et al.
Publicado: (2000)

Effect of bevacizumab treatment on p-boronophenylalanine distribution in murine tumor
por: Liu, Yong, et al.
Publicado: (2013)

Analyzing spatial distribution between (18)F-fluorodeoxyglucose and (18)F-boronophenylalanine positron emission tomography to investigate selection indicators for boron neutron capture therapy
por: Nakaichi, Tetsu, et al.
Publicado: (2022)

Carborane-Containing Hydroxamate MMP Ligands for the Treatment of Tumors Using Boron Neutron Capture Therapy (BNCT): Efficacy without Tumor Cell Entry
por: Flieger, Sebastian, et al.
Publicado: (2023)

Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using (10)B-p-Boronophenylalanine (BPA) with Special Reference to the Radiobiological Basis and Clinical Results
por: Fukuda, Hiroshi
Publicado: (2021)

Role of p53 mutation in the effect of boron neutron capture therapy on oral squamous cell carcinoma
por: Fujita, Yusei, et al.
Publicado: (2009)

Responses of Total and Quiescent Cell Populations in Solid Tumors to Boron and Gadolinium Neutron Capture Reaction Using Neutrons with Two Different Energy Spectra
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1998)

Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-up
por: Takai, Satoshi, et al.
Publicado: (2021)

Development of optimization method for uniform dose distribution on superficial tumor in an accelerator-based boron neutron capture therapy system
por: Sasaki, Akinori, et al.
Publicado: (2023)

Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer
por: Suzuki, Minoru, et al.
Publicado: (2014)

ACT-02 BORON NEUTRONS CAPTURE THERAPY FOR RECURRENT HIGH-GRADE MENINGIOMAS, FROM REACTOR TO ACCELERATOR
por: Miyatake, Shin-Ichi, et al.
Publicado: (2019)

Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
por: Miyatake, Shin-Ichi, et al.
Publicado: (2014)

Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT)
por: Hiratsuka, Junichi, et al.
Publicado: (2020)

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer
por: Barth, Rolf F, et al.
Publicado: (2012)

A Novel Boron Lipid to Modify Liposomal Surfaces for Boron Neutron Capture Therapy
por: Shirakawa, Makoto, et al.
Publicado: (2021)

Induced radioactivity in the blood of cancer patients following Boron Neutron Capture Therapy
por: Fujiwara, Keiko, et al.
Publicado: (2013)

Sonoporation as an enhancing method for boron neutron capture therapy for squamous cell carcinomas
por: Yamatomo, Naofumi, et al.
Publicado: (2013)

Biodistribution of Boron Concentration on Melanoma‐bearing Hamsters after Administration of p‐, m‐, o‐Boronophenylalanine
por: Hiratsuka, Junichi, et al.
Publicado: (2000)

Design, Synthesis, and Biological Evaluation of Boron-Containing Macrocyclic Polyamines and Their Zinc(II) Complexes for Boron Neutron Capture Therapy
por: Ueda, Hiroki, et al.
Publicado: (2021)

Theranostics in Boron Neutron Capture Therapy
por: Sauerwein, Wolfgang A. G., et al.
Publicado: (2021)

The Combined Effect of Electroporation and Borocaptate in Boron Neutron Capture Therapy for Murine Solid Tumors
por: Ono, Koji, et al.
Publicado: (2000)

Evaluation of the Potential of p‐Boronophenylalaninol as a Boron Carrier in Boron Neutron Capture Therapy, Referring to the Effect on Intratumor Quiescent Cells
por: Masunaga, Shin‐ichiro, et al.
Publicado: (2001)

The impact of TP53 status of tumor cells including the type and the concentration of administered (10)B delivery agents on compound biological effectiveness in boron neutron capture therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2023)

Microdosimetric quantities of an accelerator-based neutron source used for boron neutron capture therapy measured using a gas-filled proportional counter
por: Hu, Naonori, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_joobce060vcfbffsl0g3u8ke65